🔎 Trials Near Me

Hjem › Diffus sclerodermi › Illinois › Chicago

Diffus sclerodermi kliniske forsøg i Chicago, IL

7 studier for Diffus sclerodermi søger deltagere på steder i og omkring Chicago (inden for ca. 30 miles). Åbn et studie for at se, hvem der kan deltage, og hvordan man kontakter studieteamet.

Officiel studietekst (engelsk)

Rekrutterer til et studie her? Få det vist øverst på siden — $99 i 30 dage →

A Clinical Study to Evaluate Ianalumab in Participants With Diffuse Cutaneous Systemic Sclerosis

RekruttererFase 2
  • University of Chicago Hospitals, Chicago
Alder 18 til 70 · Alle køn · Opdateret 28. sep. 2026 · NCT06470048

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

RekruttererFase 1
  • The University of Chicago Medical Center, Chicago
Alder 18 til 74 · Alle køn · Opdateret 10. sep. 2026 · NCT07085104

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

RekruttererFase 2/3
  • GSK Investigational Site, Chicago
Alder 18 og opefter · Alle køn · Opdateret 8. sep. 2026 · NCT05878717

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

RekruttererFase 1
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago
Alder 18 til 70 · Alle køn · Opdateret 28. aug. 2026 · NCT06925542

Platform Clinical Study for Conquering Scleroderma

RekruttererFase 2
  • The University of Chicago Medical Center (UCMC), Chicago
Alder 18 og opefter · Alle køn · Opdateret 18. aug. 2026 · NCT06195072

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

RekruttererFase 2/3
  • Northwestern Memorial Hospital, Chicago
  • The University of Chicago Medical Center, Chicago
Alder 18 til 75 · Alle køn · Opdateret 17. aug. 2026 · NCT06328777

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

RekruttererFase 1/2
  • Nkarta Investigational Site, Chicago
Alder 18 til 75 · Alle køn · Opdateret 7. aug. 2026 · NCT06733935

Diffus sclerodermi forsøg i andre byer

Andre studier i Chicago

Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.